Becton, Dickinson and Company Share Price Swiss Exchange
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
243.4 CHF | +0.72% |
|
-.--% | -.--% |
Sales 2024 * | 2.02TCr 1.81TCr 1,69000Cr | Sales 2025 * | 2.15TCr 1.92TCr 1,79300Cr | Capitalization | 6.61TCr 5.92TCr 5,52100Cr |
---|---|---|---|---|---|
Net income 2024 * | 209.4Cr 187.54Cr 17TCr | Net income 2025 * | 247.9Cr 222.03Cr 21TCr | EV / Sales 2024 * | 3.91 x |
Net Debt 2024 * | 1.31TCr 1.18TCr 1,09600Cr | Net Debt 2025 * | 1.08TCr 966.85Cr 90TCr | EV / Sales 2025 * | 3.58 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
28.5
x | Employees | - |
Yield 2024 * |
1.64% | Yield 2025 * |
1.68% | Free-Float | 77.74% |
Latest transcript on Becton, Dickinson and Company
![Extreme 206.207979](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 01/09/01 |
Director of Finance/CFO | 52 | 06/21/06 | |
Chief Tech/Sci/R&D Officer | 48 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 24/02/24 |
Catherine Burzik
BRD | Director/Board Member | 73 | 29/13/29 |
Director/Board Member | 69 | 26/10/26 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.50% | 18TCr | |
-5.79% | 9.9TCr | |
-8.38% | 4.41TCr | |
+8.42% | 4.38TCr | |
+10.10% | 4.27TCr | |
+10.97% | 2.89TCr | |
+18.89% | 2.51TCr | |
-8.39% | 2.34TCr | |
-11.25% | 2.19TCr |
- Stock Market
- Equities
- BDX Stock
- BDX Stock